Foresite Capital
Highly Engaged Employees
Highly Engaged EmployeesFinance · California, United States · 11-50 Employees
View Company Info for Free
Overview
Headquarters
9200 W Sunset Blvd Ste 515, West Hollywo...Phone Number
(310) 981-3630Website
www.foresitecapital.comRevenue
$16.9 MillionIndustry
ZI Rank: 3
Signal Type
Dec
Jan
Feb
Mar
Apr
May
ZI Rank
2
2
2
2
2
3
About Foresite Capital
Foresite Capital is a multi-stage investment firm focused on transforming healthcare and life sciences by investing in companies that utilize biology and big data. The firm targets breakthrough opportunities at the intersection of technology and biotechnology, employing a data science-driven investment approach. Their mission is to address significant unmet needs in healthcare by funding visionary businesses at various stages of their development. Foresite Capital aims to support innovators who are changing the landscape of healthcare through strategic partnerships and deep industry expertise.Explore more
Foresite Capital Org Chart
Sell smarter with deeper company insights.
ZoomInfo gives you access to real-time firmographics, buying signals, org charts, and decision-makers - helping your GTM teams prioritize accounts, personalize outreach with AI-driven automation, and close deals faster.
Is Foresite Capital your ideal customer? 
Let us give you the heads up on whether it's a good time to reach out
Website visits: Recent activity has been detected on your website
Check out if Foresite Capital is spiking on competitors!
Congratulate Masked Content for being promoted to Masked Content at Foresite Capital
Earning: See what the market has to say on Foresite Capital recently announced quarterly report
Click to see if Foresite Capital had a recent Job posting/layoffs
Funding: Get notified immidiatlly once Foresite Capital has new funding data
Product Launch: Get notified when Foresite Capital launches new products
Competitive Alert! Recent activity has been detected by your competitor Masked Content
Foresite Capital, which may be a good buyer, showed buying intent in Masked Content Topic
Check if Foresite Capital has recently received funding, and reach out quickly before it becomes old news!
Recommended Actions
Reach out to Masked Content who joined Foresite Capital as Masked Content
Find 3 more new buyers
Compare Similar Companies to Foresite Capital
Compare insights from companies similar to Foresite Capital, focusing on performance, financial data, growth rates, and unique benchmarks to identify key industry trends and opportunities.
Revenue
Number of Employees
Type
Funding
Founded In
Company Profile Activity
Activity Insights
Foresite Capital is experiencing very low activity levels compared to other companies in the Finance sector.
What does this means?
Foresite Capital is drawing exceptional interest within the Finance industry, suggesting notable developments or strong market momentum, learn more about Foresite Capital.
Foresite Capital Tech Stack
A closer look at the technologies used by Foresite Capital
See more technologies
Most Recent Scoops
Person-Based
Project
Spending/Investment
Person-Based
Funding, Business Finance, Finance
Project
Spending/Investment
Project
Spending/Investment
Foresite Capital News & Media
RayThera Raises $110 Million in Series A Financing - Business Wire
RayThera raises $110 million in Series A financing to support advancement of preclinical immunology pipelineEikon Therapeutics Raises $350.7M in Series D Funding
Eikon Therapeutics, a Hayward, CA-based pivotal-stage biotechnology company for drug discovery and development, raised $350.7M in Series D funding. The investment syndicate was composed of mutual funds, sovereign wealth funds, and healthcare and technology-focused venture firms including Lux Capital, Alexandria Venture Investments, AME Cloud Ventures, The Column Group, E15 VC, Foresite Capital, General Catalyst, Soros […] The post Eikon Therapeutics Raises $350.7M in Series D Funding appeared fiAbcuro Raises $200M in Series C Financing
Abcuro, a Newton, MA-based clinical-stage biotechnology company, raised $200M in Series C funding. The round was led by New Enterprise Associates (NEA) joined by Foresite Capital with participation from existing investors including RA Capital Management, Bain Capital Life Sciences, Redmile Group, Samsara BioCapital, Sanofi Ventures, Pontifax, Mass General Brigham Ventures, New Leaf Ventures, abrdn Inc., […] The post Abcuro Raises $200M in Series C Financing appeared first on FinSMEs.Pleno Closes $25M Series B & Appoints Dr. Vik Vaz as CEO - HIT Consultant
Pleno announced it has raised $25M in Series B funding and appointed Dr. Vik Vaz as its new Chief Executive Officer (CEO).
Read more news
Top Finance Companies
Top companies in Canada by revenue
Top companies in Australia by revenue
Top companies in New Zealand by revenue
Frequently Asked Questions Regarding Foresite Capital
Sign Up For FreeTo access detailed company insights
Foresite Capital is a multi-stage investment firm focused on transforming healthcare and life sciences by investing in companies that utilize biology and big data. The firm targets breakthrough opportunities at the intersection of technology and biotechnology, employing a data science-driven investment approach. Their mission is to address signific... Read More
